000 | 01060 a2200313 4500 | ||
---|---|---|---|
005 | 20250511141256.0 | ||
264 | 0 | _c19800417 | |
008 | 198004s 0 0 eng d | ||
022 | _a0361-5960 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCasper, E S | |
245 | 0 | 0 |
_aPhase II study of high-dose cis-dichlorodiammineplatinum(II) in the treatment of non-small cell lung cancer. _h[electronic resource] |
260 |
_bCancer treatment reports _c |
||
300 |
_a2107-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aBone Marrow _xdrug effects |
650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
650 | 0 | 4 | _aDrug Evaluation |
650 | 0 | 4 |
_aHearing _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney _xdrug effects |
650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aVomiting _xchemically induced |
700 | 1 | _aGralla, R J | |
700 | 1 | _aKelsen, D P | |
700 | 1 | _aCvitkovic, E | |
700 | 1 | _aGolbey, R B | |
773 | 0 |
_tCancer treatment reports _gvol. 63 _gno. 11-12 _gp. 2107-9 |
|
999 |
_c595455 _d595455 |